AnitaSabichiMD

Oncology • Houston, TX

Genitourinary Oncology, Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Assistant Professor, Hematology & Oncology, Baylor College of Medicine

Join to view full profile

Dr. Sabichi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sabichi's full profile

Already have an account?

Office
1504 Taub Loop
Houston, TX 77030
Phone+1 713-873-8890

Fax+1 713-798-6677

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1987 - 1990
University of Colorado School of Medicine Anschutz Medical CampusClass of 1987

Certifications & Licensure

NY State Medical License 1988 - 2026
TX State Medical License 1998 - 2026
MD State Medical License 1990 - 2017
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 1998 Jul 30
Completed
Phase 3
Celecoxib in Treating Patients With Bladder Cancer Start of enrollment: 2000 Jun 01
Completed
Phase 2, Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Study of Metformin With Simvastatin for Men With Prostate Carcinoma Start of enrollment: 2012 Jan 01
Withdrawn
Phase 2
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments Start of enrollment: 2019 Oct 01
Recruiting
Roles: Contact, Principal Investigator
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Start of enrollment: 2021 Aug 31
Recruiting
Phase 2
Roles: Contact
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer Start of enrollment: 2019 May 23
Recruiting
Phase 2
Roles: Contact
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC Start of enrollment: 2024 Jun 24
Not yet recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

235 citations
Focus on bladder cancer
Colin P.N. Dinney, David J. McConkey, Randall E. Millikan, Xifeng Wu, Menashe Bar-Eli
Cancer Cell. 2004-08-01
873 citations
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Peter B. Bach, Joshua N. Mirkin, Thomas K. Oliver, Christopher G. Azzoli, Donald A. Berry
JAMA. 2012-06-13
232 citations
Clinical model of lifetime cost of treating bladder cancer and associated complications.
Elenir B. C. Avritscher, Catherine D. Cooksley, H. Barton Grossman, Anita L. Sabichi, Lois Hamblin
Urology. 2006-09-01

Press Mentions

NMSU Alum, M.D. Anderson Cancer Researcher Creates ScholarshipNovember 22nd, 2020